Skip to main content
. 2013 Mar 7;8(3):e58355. doi: 10.1371/journal.pone.0058355

Figure 2. ON01210 Treatment does not alter the cell cycle progression and growth of normal cells (A) HFL-1 cells were treated with increasing concentrations of ON01210 (vehicle alone, 1 uM, 5 uM, 10 uM, 25 uM, and 50 uM) and then subjected to flow cytometric analysis.

Figure 2

(B) HFL-1 and human umbilical vein endothelial cells (HUVECS) were plated in the presence of increasing concentrations of ON01210 for 96 hours. The total number of viable cells was determined and the average percent of vehicle control was as a function of concentration.